Paralytic

From Practice Parameters
Revision as of 07:10, 13 September 2019 by Mfrdmanager (talk | contribs) (→‎Succinycholine)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Section 8 - MEDICATION GUIDELINES

8.18 PARALYTIC

Succinycholine

DESCRIPTION

  • A skeletal muscle relaxant for intravenous (IV) administration indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

INDICATIONS

CONTRAINDICATIONS

  • Do not administer to patients with Hx of HYPERKALEMIA, RHABDOMYOLYSIS, Severe Burns and Malignant hyperthermia. (i.e. peaked T waves, kidney insufficiency, renal failure, acidosis, crush injuries.)

DOSAGE

  • 1.5 mg/kg intravenously (IV) for 1 dose
  • Maintenance for Prolonged Procedures - 0.04-0.07 mg/kg intravenously (IV) every 5-10 minutes as needed
Retrieved from "http://mfrdinfo.com/ems1/index.php?title=Paralytic&oldid=27590"